Return to Vaccination News Home Page  __»   Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=abs&id=ampd03213&nav=abs

Mosby Periodicals Home Search User
Pref
Help
J Peds Home Table of
Contents
All Issues Order About this
Journal
<<
Issue
>>
Issue


 

 

   

June 2003 • Volume 142 • Number 6

 


 

Original Articles
Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: A randomized clinical trial

Dennis R. Hoffman, PhD [MEDLINE LOOKUP]
Eileen E. Birch, PhD [MEDLINE LOOKUP]
Yolanda S. Castaρeda, BSN [MEDLINE LOOKUP]
Sherry L. Fawcett, PhD [MEDLINE LOOKUP]
Dianna H. Wheaton, MS [MEDLINE LOOKUP]
David G. Birch, PhD [MEDLINE LOOKUP]
Ricardo Uauy, MD, PhD [MEDLINE LOOKUP]

• Previous article in Issue
• Next article in Issue
• View full-text version
• View print version (PDF)
• Drug links from Mosby's DrugConsult
• Genetic information from OMIM
• Citation of this Article
   • View on PubMed
   • Download in citation manager format
   • Download in Medlars format
• Related articles in PubMed
 


 

   Abstract  TOP 

Objective Breast-fed infants receive docosahexaenoic acid (DHA) and arachidonic acid (ARA) in their diet. Upon weaning, infants lose this dietary source of long-chain polyunsaturates because many commercial formulas do not contain these important constituents for neural membrane biogenesis. We evaluated the benefits of postweaning dietary supplementation of DHA + ARA on visual maturation.
Study design Healthy term infants (n = 61) were breast-fed to 4 to 6 months, then were randomly assigned to commercial formula or formula supplemented with DHA (0.36%) + ARA (0.72%). Measurements of red blood cell (RBC) fatty acids, visually evoked potential (VEP) acuity, and stereoacuity were done before and after weaning.
Results At 1 year of age, RBC-DHA in the commercial formula-fed group was reduced by 50% from the weaning level, whereas there was a 24% increase in the DHA + ARA-supplemented group. The primary outcome measure, VEP acuity, was significantly more mature in supplemented infants at 1 year of age. Elevated RBC-DHA levels were associated with more mature VEP acuity. There were no significant diet-related differences in stereoacuity.
Conclusions These data extend through the first year of life the critical period in which a dietary supply of DHA and ARA can contribute in optimizing visual development in term infants. (J Pediatr 2003;142:669-77)


 

   Publishing and Reprint Information  TOP 


 

Return to Vaccination News Home Page  __»   Right-click to "open in new window"

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.